With this issue we welcome three members to the distinguished editorial advisory board that has guided Contemporary OB/GYN since its inception.
Yalda Afshar, MD, PhD; Christine Isaacs, MD; and Laura Riley, MD begin their time in lending expertise to the content in these pages and online. You can read more about each remarkable scientist here.
We hope you also will find the content in this issue rich and informative. The Society for Maternal-Fetal Medicine (SMFM) shares its Consult Series #50 on Activity Restriction in obstetric management. Editor-in-Chief Catherine Y. Spong, MD, dedicates her editorial to the topic with an endorsement to put activity restriction to bed – her pun fully intended – as research now is available to provide guidance for practitioners recommending against its routine use.
Practitioners continue to navigate health care in a pandemic, conducting much patient communication virtually. Four doctors from Yale—Linda L. Fan, MD, FACOG; Shefali R. Pathy, MD, MPH; Julia Cron, MD; and Sangini S. Sheth, MD, MPH—offer their guidance on managing the Well Woman visit via telehealth.
In the first article of a two-part series, Amanda Kallen, MD, and Sandra Ann Carson, MD, offer a thorough guide to diagnosing an infertile couple. Watch for next month’s article as well, where they provide a guide for treatment.
Ronald J. Wapner, MD, makes a case for improved carrier screening. Ideally, women of reproductive age would be offered carrier screening before conception to maximize the subsequent reproductive options for carrier couples, he says.
Please let us know what you think of this content; reader feedback is invited by emailing Senior Editor Angie DeRosa at aderosa@mjhlifesciences.com.
__
Mike Hennessy, Sr.
Chairman and Founder, MJH Life Sciences
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More